Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales20 27219 65221 90322 63320 65020 195
EBITDA7 2406 6217 3006 8845 5625 093
Operating profit (EBIT)5 7326 1746 8476 2765 0564 716
Pre-Tax Profit (EBT)3 638-----
Net income3 055-68,0---
P/E ratio15,9-513---
EPS ( $ )3,58-0,07---
Dividend per Share ( $ )-1,361,36---
Yield-2,08%3,78%---
Reference price ( $ )57653618.183918.183918.1839
Announcement Date02/05/2015
12:00pm
02/11/2016
12:00pm
02/13/2017
11:42am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt-3 02234 81234 41927 81123 856
Finance------
Operating income (EBITDA)7 2406 6217 3006 8845 5625 093
Leverage
(Debt/EBITDA)
-0,46x4,77x5,00x5,00x4,68x
Capital Expenditure-7729011 1661 1951 225
Book Value Per Share (BVPS)--32,8 $---
Cash Flow per Share--5,12 $---
Announcement Date02/05/2015
12:00pm
02/11/2016
12:00pm
02/13/2017
11:42am
---
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 18 445 M$ -
Entreprise Value (EV) 52 864 M$ 46 256 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS)
Capitalization / Revenue 0,81x 0,89x
EV / Revenue 2,34x 2,24x
EV / EBITDA 7,68x 8,32x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 27,7% 24,5%
operating Leverage (Delta EBIT / Delta Sales) - -2,22x
Net Margin (Net Profit / Revenue) - -
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 14,0% 13,0%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   5,15% 5,79%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 5,00x 5,00x
EPS & Dividend